Healthcare & Medical Devices Global On demand · 24-48h

Global Unidirectional Barbed Suture Market Strategic Research Report

Global Unidirectional Barbed Suture Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Unidirectional Barbed Suture Market
$5022025
10.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Absorbable Material, Non-absorbable Material

By Application: General Surgery, Orthopedic Surgery, Gynecology and Obstetrics, Urology, Plastic Surgery, Oncology, Cardiothoracic Surgery, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Corza Medical, Johnson & Johnson, META BIOMED, Futura Surgicare, RESORBA Medical GmbH, Cortis, SERAG-WIESSNER, Weigao Group, Katsan Medical Devices

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 89 pages
Market size 2025
$502
Million USD
Forecast CAGR
10.4%
2025-2032
Forecast 2032
$1003.4
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Unidirectional Barbed Suture market size is predicted to grow from US$ 502 million in 2025 to US$ 989 million in 2032; it is expected to grow at a CAGR of 10.4% from 2026 to 2032.

A barbed suture is a type of knotless surgical suture that has barbs on its surface. While suturing tissue, these barbs penetrate inside the tissue and lock them into place, eliminating the need for knots to tie the suture. Conventional sutures rely on a surgeon"s ability to tie secure knots; barbed sutures provide a knotless alternative in some surgical situations. Barbed sutures are primarily used in cosmetic surgery. In recent years there has been an increasing uptake in the use of barbed sutures, particularly in minimally invasive and laparoscopic procedures where they may reduce operating time and improve surgical efficiency. However, little is known about the adverse events associated with these new materials and concerns have arisen regarding their safety in certain procedures. Although barbed sutures provide an attractive means to allow easier and faster laparoscopic suturing, they should be used carefully in inframesocolic surgery and the suture end cut and buried to avoid inadvertent attachment to the small bowel or its mesentery. which may lead to small bowel obstruction presenting in the early postoperative period. Animal study with barbed sutures (Barbed Glycomer™ 631) exhibited more cohesive bonding, no complications, and higher suture retention strength, as compared to V‐LOC™ 90 Absorbable Wound Closure Device. Uni-directional is a single armed suture. The suture is anchored using the adjustable loop at the apex of the wound.

Global key Unidirectional Barbed Suture players cover Corza Medical, Johnson & Johnson, META BIOMED, Futura Surgicare, RESORBA Medical GmbH, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Unidirectional Barbed Suture market?

What factors are driving Unidirectional Barbed Suture market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Unidirectional Barbed Suture market opportunities vary by end market size?

How does Unidirectional Barbed Suture break out by Type, by Application?

This report presents a comprehensive overview of the global Unidirectional Barbed Suture market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Absorbable Material
  • Non-absorbable Material

Segment by Application

  • General Surgery
  • Orthopedic Surgery
  • Gynecology and Obstetrics
  • Urology
  • Plastic Surgery
  • Oncology
  • Cardiothoracic Surgery
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Unidirectional Barbed Suture market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in General Surgery, Orthopedic Surgery, Gynecology and Obstetrics evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Unidirectional Barbed Suture Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$502
2025
Forecast
$1003.4
2032
CAGR
10.4%
2025–2032
Regions
5
global
Key companies
Corza MedicalJohnson & JohnsonMETA BIOMEDFutura SurgicareRESORBA Medical GmbHCortisSERAG-WIESSNERWeigao Group
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Absorbable MaterialNon-absorbable Material
By Application
General SurgeryOrthopedic SurgeryGynecology and ObstetricsUrologyPlastic SurgeryOncologyCardiothoracic SurgeryOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Absorbable Material
  • 3.1.3 Non-absorbable Material
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 General Surgery
  • 4.1.3 Orthopedic Surgery
  • 4.1.4 Gynecology and Obstetrics
  • 4.1.5 Urology
  • 4.1.6 Plastic Surgery
  • 4.1.7 Oncology
  • 4.1.8 Cardiothoracic Surgery
  • 4.1.9 Others
  • 4.1.10 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Corza Medical
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Johnson & Johnson
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 META BIOMED
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Futura Surgicare
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 RESORBA Medical GmbH
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Cortis
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 SERAG-WIESSNER
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Weigao Group
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Katsan Medical Devices
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Unidirectional Barbed Suture market?
The global Unidirectional Barbed Suture market is estimated at US$ 502 million in 2025 (base year) and is projected to reach US$ 989 million by 2032.
What is the forecast CAGR for the Unidirectional Barbed Suture market?
The market is expected to grow at a CAGR of 10.4% from 2026 to 2032, expanding from US$ 502 million in 2025 to US$ 989 million in 2032, roughly 2.0 times its base-year value.
What is Unidirectional Barbed Suture?
A barbed suture is a type of knotless surgical suture that has barbs on its surface. While suturing tissue, these barbs penetrate inside the tissue and lock them into place, eliminating the need for knots to tie the suture. Conventional sutures rely on a surgeon"s ability to tie secure knots; barbed sutures provide a knotless alternative in some surgical situations.
How is the Unidirectional Barbed Suture market segmented by type?
By type, the market is segmented into Absorbable Material and Non-absorbable Material.
What are the key applications of Unidirectional Barbed Suture?
Key applications covered include General Surgery, Orthopedic Surgery, Gynecology and Obstetrics, Urology, Plastic Surgery, Oncology, Cardiothoracic Surgery and Others.
Which companies are profiled in the Unidirectional Barbed Suture market report?
Key players profiled include Corza Medical, Johnson & Johnson, META BIOMED, Futura Surgicare, RESORBA Medical GmbH, Cortis, SERAG-WIESSNER and Weigao Group, among 9 companies covered in total.
What geographies does the Unidirectional Barbed Suture market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Unidirectional Barbed Suture?
What factors are driving Unidirectional Barbed Suture market growth, globally and by region?
Who should buy the Unidirectional Barbed Suture market report?
The report is intended for manufacturers and solution providers, distributors and end users in General Surgery, Orthopedic Surgery and Gynecology and Obstetrics, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Unidirectional Barbed Suture market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.